thymidine has been researched along with sulindac in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awad, J; Bishop, PR; DuBois, RN; Morrow, J; Roberts, LJ | 1 |
| Bruce, JN; Delohery, TM; Fetter, J; Gundersen, GG; Palazzo, AF; Pamukcu, R; Sperl, G; Thompson, WJ; Warburton, PE; Weinstein, IB; Whitehead, C; Xiao, D; Yoon, JT | 1 |
2 other study(ies) available for thymidine and sulindac
| Article | Year |
|---|---|
Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.
Topics: Animals; Cell Division; Cell Line; DNA; DNA Probes; Eicosanoids; Electron Transport Complex IV; Enzyme Induction; Epithelial Cells; Epithelium; Gene Expression Regulation, Enzymologic; Indomethacin; Intestinal Mucosa; Kinetics; Mice; Microsomes; Prostaglandin-Endoperoxide Synthases; Rats; RNA, Messenger; Sulindac; Tetradecanoylphorbol Acetate; Thymidine; Transfection; Transforming Growth Factor alpha | 1994 |
CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle Proteins; Cell Division; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 5; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Glioma; Humans; Immunoenzyme Techniques; In Vitro Techniques; Interphase; Kinesins; Mice; Microtubules; Phosphoproteins; Phosphoric Diester Hydrolases; Rats; Spindle Apparatus; Sulindac; Thymidine | 2002 |